-+ 0.00%
-+ 0.00%
-+ 0.00%

Citigroup Maintains Buy on Evolent Health, Raises Price Target to $5.5

Benzinga·05/15/2026 18:28:01
Listen to the news
Citigroup analyst Daniel Grosslight maintains Evolent Health (NYSE:EVH) with a Buy and raises the price target from $4 to $5.5.